The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor - PubMed (original) (raw)
. 1996 Dec 20;271(51):32863-8.
doi: 10.1074/jbc.271.51.32863.
Affiliations
- PMID: 8955125
- DOI: 10.1074/jbc.271.51.32863
Free article
The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor
C F Chen et al. J Biol Chem. 1996.
Free article
Abstract
The BRCA1 gene product is a nuclear phosphoprotein that is aberrantly localized in the cytoplasm of most breast cancer cells. In an attempt to elucidate the potential mechanism for the nuclear transport of BRCA1 protein, three regions of highly charged, basic residues, 503KRKRRP508, 606PKKNRLRRKS615, and 651KKKKYN656, were identified as potential nuclear localization signals (NLSs). These three regions were subsequently mutated to 503KLP508, 607KLS615, and 651KLN656, respectively. Wild-type and mutated proteins were tagged with the flag epitope, expressed in human DU145 cells, and detected with the M2 monoclonal antibody. In DU145 cells, the KLP mutant completely fails to localize in nuclei, whereas the KLS mutant is mostly cytoplasmic with occasional nuclear localization. The KLN protein is always located in nuclei. Consistently, hSRP1alpha (importin-alpha), a component of the NLS receptor complex, was identified in a yeast two-hybrid screen using BRCA1 as the bait. The specificity of the interaction between BRCA1 and importin-alpha was further demonstrated by showing that the 503KRKRRP508 and 606PKKNRLRRKS615 regions, but not 651KKKKYN656, are critical for this interaction. To determine if the cytoplasmic mislocation of endogenous BRCA1 in breast cancer cells is due to a deficiency of the cells, wild-type BRCA1 protein tagged with the flag epitope was ectopically expressed in six breast cancer cell lines. The analysis demonstrated that, in all six, this protein localized in the cytoplasm of these cells. In contrast, expression of the construct in four non-breast cancer cell lines resulted in nuclear localization. These data support the possibility that the mislocation of the BRCA1 protein in breast cancer cells may be due to a defect in the cellular machinery involved in the NLS receptor-mediated pathway of nuclear import.
Similar articles
- Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53.
Kim IS, Kim DH, Han SM, Chin MU, Nam HJ, Cho HP, Choi SY, Song BJ, Kim ER, Bae YS, Moon YH. Kim IS, et al. J Biol Chem. 2000 Jul 28;275(30):23139-45. doi: 10.1074/jbc.M909256199. J Biol Chem. 2000. PMID: 10930427 - Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs.
Li S, Ku CY, Farmer AA, Cong YS, Chen CF, Lee WH. Li S, et al. J Biol Chem. 1998 Mar 13;273(11):6183-9. doi: 10.1074/jbc.273.11.6183. J Biol Chem. 1998. PMID: 9497340 - Identification of a functional nuclear export sequence in BRCA1.
Rodríguez JA, Henderson BR. Rodríguez JA, et al. J Biol Chem. 2000 Dec 8;275(49):38589-96. doi: 10.1074/jbc.M003851200. J Biol Chem. 2000. PMID: 10991937 - Nuclear trafficking of photoreceptor protein crx: the targeting sequence and pathologic implications.
Fei Y, Hughes TE. Fei Y, et al. Invest Ophthalmol Vis Sci. 2000 Sep;41(10):2849-56. Invest Ophthalmol Vis Sci. 2000. PMID: 10967037 - BRCA1 16 years later: nuclear import and export processes.
Thompson ME. Thompson ME. FEBS J. 2010 Aug;277(15):3072-8. doi: 10.1111/j.1742-4658.2010.07733.x. Epub 2010 Jul 1. FEBS J. 2010. PMID: 20608972 Review.
Cited by
- Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci.
Huber LJ, Yang TW, Sarkisian CJ, Master SR, Deng CX, Chodosh LA. Huber LJ, et al. Mol Cell Biol. 2001 Jun;21(12):4005-15. doi: 10.1128/MCB.21.12.4005-4015.2001. Mol Cell Biol. 2001. PMID: 11359908 Free PMC article. - Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Lavoro A, Scalisi A, Candido S, Zanghì GN, Rizzo R, Gattuso G, Caruso G, Libra M, Falzone L. Lavoro A, et al. Int J Oncol. 2022 May;60(5):58. doi: 10.3892/ijo.2022.5349. Epub 2022 Apr 6. Int J Oncol. 2022. PMID: 35383859 Free PMC article. - The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers.
Paul A, Paul S. Paul A, et al. Front Biosci (Landmark Ed). 2014 Jan 1;19(4):605-18. doi: 10.2741/4230. Front Biosci (Landmark Ed). 2014. PMID: 24389207 Free PMC article. Review. - Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent.
Glover-Collins K, Thompson ME. Glover-Collins K, et al. Cell Signal. 2008 May;20(5):958-68. doi: 10.1016/j.cellsig.2008.01.007. Epub 2008 Jan 19. Cell Signal. 2008. PMID: 18296025 Free PMC article. - The antitumorigenic roles of BRCA1-BARD1 in DNA repair and replication.
Tarsounas M, Sung P. Tarsounas M, et al. Nat Rev Mol Cell Biol. 2020 May;21(5):284-299. doi: 10.1038/s41580-020-0218-z. Epub 2020 Feb 24. Nat Rev Mol Cell Biol. 2020. PMID: 32094664 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous